One of the great things about equity markets is that you don't need a fortune to get started. Though strong companies that ...

Shares of early-stage biotech stocks, including Biohaven ( BHVN -6.50%), Recursion Pharmaceuticals ( RXRX -7.37%), and CRISPR ...

Life sciences companies have decided to chop hundreds of Bay Area jobs in a fresh wave of layoffs that hint at ongoing ...

The founder of menopause startup Gennev steps down, while the CEO and founder of Aurion Biotech is pushed out, plus other ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

The biotech, which has raised more than $140 million over several investment rounds in the last few years from the likes of ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

After struggling through a rough patch, the biotech industry seems to be staging a comeback. Several biotech firms have gone ...

Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a research ...